Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0481 Transporter Info
Gene Name	SLC9A1
Transporter Name	Sodium/hydrogen exchanger 1
Gene ID	6548
UniProt ID	P19634

Post-Translational Modification of This DT
Overview of SLC9A1 Modification Sites with Functional and Structural Information
Sequence	M V L R S G I C G L S P H R I F P S L L V V V A L V G L L P V L R S H G L Q L S P T A S T I R S S E P P R E R S I G D V T T A P P E V T P E S R P V N H S V T D H G M K P R K A F P V L G I D Y T H V R T P F E I S L W I L L A C L M K I G F H V I P T I S S I V P E S C L L I V V G L L V G G L I K G V G E T P P F L Q S D V F F L F L L P P I I L D A G Y F L P L R Q F T E N L G T I L I F A V V G T L W N A F F L G G L M Y A V C L V G G E Q I N N I G L L D N L L F G S I I S A V D P V A V L A V F E E I H I N E L L H I L V F G E S L L N D A V T V V L Y H L F E E F A N Y E H V G I V D I F L G F L S F F V V A L G G V L V G V V Y G V I A A F T S R F T S H I R V I E P L F V F L Y S Y M A Y L S A E L F H L S G I M A L I A S G V V M R P Y V E A N I S H K S H T T I K Y F L K M W S S V S E T L I F I F L G V S T V A G S H H W N W T F V I S T L L F C L I A R V L G V L G L T W F I N K F R I V K L T P K D Q F I I A Y G G L R G A I A F S L G Y L L D K K H F P M C D L F L T A I I T V I F F T V F V Q G M T I R P L V D L L A V K K K Q E T K R S I N E E I H T Q F L D H L L T G I E D I C G H Y G H H H W K D K L N R F N K K Y V K K C L I A G E R S K E P Q L I A F Y H K M E M K Q A I E L V E S G G M G K I P S A V S T V S M Q N I H P K S L P S E R I L P A L S K D K E E E I R K I L R N N L Q K T R Q R L R S Y N R H T L V A D P Y E E A W N Q M L L R R Q K A R Q L E Q K I N N Y L T V P A H K L D S P T M S R A R I G S D P L A Y E P K E D L P V I T I D P A S P Q S P E S V D L V N E E L K G K V L G L S R D P A K V A E E D E D D D G G I M M R S K E T S S P G T D D V F T P A P S D S P S S Q R I Q R C L S D P G P H P E P G E G E P F F P K G Q
PTM type	X-N-glycosylation X-O-glycosylation X-Oxidation X-Palmitoylation X-Phosphorylation X-Ubiquitination X: Amino Acid

N-glycosylation
Asparagine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC9A1			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	75
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC9A1 Asparagine 75 has the potential to affect its expression or activity.
O-glycosylation
Asparagine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC9A1			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	75
Experimental Material(s)	Hamster fibroblasts
Experimental Method	Co-Immunoprecipitation
Detailed Description	O-glycosylation at SLC9A1 Asparagine 75 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC9A1			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	370
Experimental Material(s)	Hamster fibroblasts
Experimental Method	Co-Immunoprecipitation
Detailed Description	O-glycosylation at SLC9A1 Asparagine 370 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC9A1			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	410
Experimental Material(s)	Hamster fibroblasts
Experimental Method	Co-Immunoprecipitation
Detailed Description	O-glycosylation at SLC9A1 Asparagine 410 has the potential to affect its expression or activity.
Serine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC9A1			[2]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	697
Experimental Method	Co-Immunoprecipitation
Detailed Description	O-linked Glycosylation at SLC9A1 Serine 697 has the potential to affect its expression or activity.
Oxidation
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC9A1			[3]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	794
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SLC9A1 Cystine 794 has the potential to affect its expression or activity.
Palmitoylation
Unclear Residue	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Incerasing the activity of SLC9A1			[4]
Role of PTM	Protein Activity Modulation
Experimental Material(s)	Lung fibroblast PSN cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Palmitoylation at SLC9A1 have been reported to incerase its transport activity.
Phosphorylation
Serine	27 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC9A1			[5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	5
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A1 Serine 5 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC9A1			[5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	11
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A1 Serine 11 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC9A1			[5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	18
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A1 Serine 18 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC9A1			[6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	344
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A1 Serine 344 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC9A1			[6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	351
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A1 Serine 351 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC9A1			[6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	359
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A1 Serine 359 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC9A1			[7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	372
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A1 Serine 372 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC9A1			[8] , [9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	599
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A1 Serine 599 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SLC9A1			[8] , [9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	602
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A1 Serine 602 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence SLC9A1			[8] , [10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	605
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A1 Serine 605 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence SLC9A1			[11] , [12]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	616
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A1 Serine 616 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence SLC9A1			[11] , [13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	624
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A1 Serine 624 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence SLC9A1			[14] , [15]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	648
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A1 Serine 648 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence SLC9A1			[9] , [16]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	693
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A1 Serine 693 has the potential to affect its expression or activity.
PTM Phenomenon 15	Have the potential to influence SLC9A1			[8] , [10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	697
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A1 Serine 697 has the potential to affect its expression or activity.
PTM Phenomenon 16	Have the potential to influence SLC9A1			[9] , [16]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	703
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A1 Serine 703 has the potential to affect its expression or activity.
PTM Phenomenon 17	Have the potential to influence SLC9A1			[10] , [17]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	723
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A1 Serine 723 has the potential to affect its expression or activity.
PTM Phenomenon 18	Have the potential to influence SLC9A1			[10] , [17]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	726
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A1 Serine 726 has the potential to affect its expression or activity.
PTM Phenomenon 19	Have the potential to influence SLC9A1			[10] , [17]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	729
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A1 Serine 729 has the potential to affect its expression or activity.
PTM Phenomenon 20	Have the potential to influence SLC9A1			[18] , [19]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	766
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A1 Serine 766 has the potential to affect its expression or activity.
PTM Phenomenon 21	Have the potential to influence SLC9A1			[19] , [20]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	770
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A1 Serine 770 has the potential to affect its expression or activity.
PTM Phenomenon 22	Have the potential to influence SLC9A1			[19] , [21]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	771
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A1 Serine 771 has the potential to affect its expression or activity.
PTM Phenomenon 23	Have the potential to influence SLC9A1			[8] , [9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	783
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A1 Serine 783 has the potential to affect its expression or activity.
PTM Phenomenon 24	Have the potential to influence SLC9A1			[9] , [16]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	785
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A1 Serine 785 has the potential to affect its expression or activity.
PTM Phenomenon 25	Have the potential to influence SLC9A1			[8] , [9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	787
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A1 Serine 787 has the potential to affect its expression or activity.
PTM Phenomenon 26	Have the potential to influence SLC9A1			[8] , [22]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	788
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A1 Serine 788 has the potential to affect its expression or activity.
PTM Phenomenon 27	Have the potential to influence SLC9A1			[8] , [23]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	796
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A1 Serine 796 has the potential to affect its expression or activity.
Threonine	10 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC9A1			[24]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	68
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A1 Threonine 68 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC9A1			[24]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	79
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A1 Threonine 79 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC9A1			[8] , [25]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	603
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A1 Threonine 603 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC9A1			[5] , [14]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	653
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A1 Threonine 653 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC9A1			[26] , [27]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	685
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A1 Threonine 685 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC9A1			[8] , [28]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	695
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A1 Threonine 695 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC9A1			[17] , [29]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	718
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A1 Threonine 718 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC9A1			[19] , [21]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	769
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A1 Threonine 769 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SLC9A1			[19] , [20]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	774
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A1 Threonine 774 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence SLC9A1			[19] , [30]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	779
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A1 Threonine 779 has the potential to affect its expression or activity.
Tyrosine	6 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC9A1			[6]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	342
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A1 Tyrosine 342 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC9A1			[31] , [32]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	577
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A1 Tyrosine 577 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC9A1			[14]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	649
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A1 Tyrosine 649 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC9A1			[31] , [33]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	659
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A1 Tyrosine 659 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC9A1			[20] , [26]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	683
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A1 Tyrosine 683 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC9A1			[25] , [34]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	708
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A1 Tyrosine 708 has the potential to affect its expression or activity.
Ubiquitination
Lysine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC9A1			[35] , [36]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	583
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC9A1 Lysine 583 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC9A1			[35] , [36]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	612
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC9A1 Lysine 612 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC9A1			[35] , [36]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	738
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC9A1 Lysine 738 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC9A1			[35] , [36]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	750
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC9A1 Lysine 750 has the potential to affect its expression or activity.
Unclear Residue	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Decreasing cell surface expression of SLC9A1			[37]
Role of PTM	Surface Expression Modulation
Related Enzyme	E3 ubiquitin-protein ligase NEDD4 (NEDD4)
Experimental Material(s)	Human embryonic kidney 293 (HEK293) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC9A1 have been reported to decrease its cell surface expression.

References
1	The Na+/H+ exchanger NHE-1 possesses N- and O-linked glycosylation restricted to the first N-terminal extracellular domain. Biochemistry. 1994 Aug 30;33(34):10463-9.
2	A triarylphosphine-trimethylpiperidine reagent for the one-step derivatization and enrichment of protein post-translational modifications and identification by mass spectrometry. Chem Commun (Camb). 2018 Dec 6;54(98):13790-13793.
3	A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
4	Sodium hydrogen exchanger (NHE1) palmitoylation and potential functional regulation. Life Sci. 2022 Jan 1;288:120142.
5	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
6	Quantitative phosphoproteomics analysis reveals a key role of insulin growth factor 1 receptor (IGF1R) tyrosine kinase in human sperm capacitation. Mol Cell Proteomics. 2015 Apr;14(4):1104-12.
7	Temporal profiling of lapatinib-suppressed phosphorylation signals in EGFR/HER2 pathways. Mol Cell Proteomics. 2012 Dec;11(12):1741-57.
8	Robust, Reproducible, and Economical Phosphopeptide Enrichment Using Calcium Titanate. J Proteome Res. 2019 Mar 1;18(3):1411-1417.
9	Global phosphoproteomic analysis reveals ARMC10 as an AMPK substrate that regulates mitochondrial dynamics. Nat Commun. 2019 Jan 10;10(1):104.
10	UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515.
11	Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 Jun 2;534(7605):55-62.
12	Combined Quantification of the Global Proteome, Phosphoproteome, and Proteolytic Cleavage to Characterize Altered Platelet Functions in the Human Scott Syndrome. Mol Cell Proteomics. 2016 Oct;15(10):3154-3169.
13	Deep Coverage of Global Protein Expression and Phosphorylation in Breast Tumor Cell Lines Using TMT 10-plex Isobaric Labeling. J Proteome Res. 2017 Mar 3;16(3):1121-1132.
14	HIV-1 Activates T Cell Signaling Independently of Antigen to Drive Viral Spread. Cell Rep. 2017 Jan 24;18(4):1062-1074.
15	Quantitative phosphoproteomics unveils temporal dynamics of thrombin signaling in human endothelial cells. Blood. 2014 Mar 20;123(12):e22-36.
16	Capillary Zone Electrophoresis-Tandem Mass Spectrometry for Large-Scale Phosphoproteomics with the Production of over 11,000 Phosphopeptides from the Colon Carcinoma HCT116 Cell Line. Anal Chem. 2019 Feb 5;91(3):2201-2208.
17	p38-MK2 signaling axis regulates RNA metabolism after UV-light-induced DNA damage. Nat Commun. 2018 Mar 9;9(1):1017.
18	Unique signalling connectivity of FGFR3-TACC3 oncoprotein revealed by quantitative phosphoproteomics and differential network analysis. Oncotarget. 2017 Oct 25;8(61):102898-102911.
19	An orthogonal proteomic survey uncovers novel Zika virus host factors. Nature. 2018 Sep;561(7722):253-257.
20	An integrated strategy for highly sensitive phosphoproteome analysis from low micrograms of protein samples. Analyst. 2018 Jul 23;143(15):3693-3701.
21	Quantitative phosphoproteomic analysis identifies novel functional pathways of tumor suppressor DLC1 in estrogen receptor positive breast cancer. PLoS One. 2018 Oct 2;13(10):e0204658.
22	Global Ion Suppression Limits the Potential of Mass Spectrometry Based Phosphoproteomics. J Proteome Res. 2019 Jan 4;18(1):493-507.
23	A Methodological Assessment and Characterization of Genetically-Driven Variation in Three Human Phosphoproteomes. Sci Rep. 2018 Aug 14;8(1):12106.
24	iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
25	Combined inhibition of receptor tyrosine and p21-activated kinases as a therapeutic strategy in childhood ALL. Blood Adv. 2018 Oct 9;2(19):2554-2567.
26	Phosphoproteomic-based kinase profiling early in influenza virus infection identifies GRK2 as antiviral drug target. Nat Commun. 2018 Sep 11;9(1):3679.
27	Phosphoproteomic analysis reveals PAK2 as a therapeutic target for lapatinib resistance in HER2-positive breast cancer cells. Biochem Biophys Res Commun. 2018 Oct 20;505(1):187-193.
28	Phosphoproteomic screening identifies physiological substrates of the CDKL5 kinase. EMBO J. 2018 Dec 14;37(24):e99559.
29	Phosphoproteome Analysis Reveals Differential Mode of Action of Sorafenib in Wildtype and Mutated FLT3 Acute Myeloid Leukemia (AML) Cells. Mol Cell Proteomics. 2017 Jul;16(7):1365-1376.
30	Integrated Proteomics Reveals Apoptosis-related Mechanisms Associated with Placental Malaria. Mol Cell Proteomics. 2019 Feb;18(2):182-199.
31	Ultra-deep tyrosine phosphoproteomics enabled by a phosphotyrosine superbinder. Nat Chem Biol. 2016 Nov;12(11):959-966.
32	Protein kinase C-alpha interaction with F0F1-ATPase promotes F0F1-ATPase activity and reduces energy deficits in injured renal cells. J Biol Chem. 2015 Mar 13;290(11):7054-66.
33	Sensitive, Robust, and Cost-Effective Approach for Tyrosine Phosphoproteome Analysis. Anal Chem. 2017 Sep 5;89(17):9307-9314.
34	CEP128 Localizes to the Subdistal Appendages of the Mother Centriole and Regulates TGF-beta/BMP Signaling at the Primary Cilium. Cell Rep. 2018 Mar 6;22(10):2584-2592.
35	A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol Cell Proteomics. 2011 Oct;10(10):M111.013284.
36	Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011 Oct 21;44(2):325-40.
37	Nedd4-1 and beta-arrestin-1 are key regulators of Na+/H+ exchanger 1 ubiquitylation, endocytosis, and function. J Biol Chem. 2010 Dec 3;285(49):38293-303.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence